T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy

Riccardo Alessandro, Guido Sireci, Francesco Dieli, Giovanni Triolo, Diana Di Liberto, Giuliana Guggino, Marianna Lo Pizzo, Filippo Brighina, Stefania Raimondo, Piercarlo Sarzi-Puttini, Piero Ruscitti, Domenico Garbo, Roberto Giacomelli, Roberto Casale, Claudia Schinocca, Domenico Garbo

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Hyperbaric oxygen therapy (HBOT) has been used as treatment for different clinical conditions, including fibromyalgia (FM). HBOT modulates brain activity, ameliorates chronic pain and modifies the ratio of immune cells. Clinical studies have provided evidence that FM is associated with immune system dysregulation. In the present study we aimed to evaluate the effect of HBOT on immune system and on the quality of life-style of FM patients.
Original languageEnglish
Pages (from-to)81-89
Number of pages9
JournalClinical and Experimental Rheumatology
Volume37 Suppl 116
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy'. Together they form a unique fingerprint.

Cite this